BJCM

Blue Jay Capital Management Portfolio holdings

AUM $147M
1-Year Est. Return 64.18%
This Quarter Est. Return
1 Year Est. Return
+64.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$147M
AUM Growth
-$56.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
30
New
Increased
Reduced
Closed

Top Buys

1
+$7.31M
2
+$6.97M
3
+$6.74M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$6.68M
5
BKD icon
Brookdale Senior Living
BKD
+$6.62M

Top Sells

1
+$12.7M
2
+$11.8M
3
+$11.3M
4
BMY icon
Bristol-Myers Squibb
BMY
+$10.9M
5
BCR
CR Bard Inc.
BCR
+$9.3M

Sector Composition

1 Healthcare 89.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$9.44M 6.43%
67,490
-17,159
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
$9.28M 6.32%
99,101
-50,899
INCY icon
3
Incyte
INCY
$20.8B
$9.07M 6.18%
72,051
+2,373
IRWD icon
4
Ironwood Pharmaceuticals
IRWD
$312M
$8.87M 6.05%
561,180
-244,770
WMGI
5
DELISTED
Wright Medical Group Inc
WMGI
$8.81M 6%
320,420
+14,255
BMRN icon
6
BioMarin Pharmaceuticals
BMRN
$9.89B
$8.58M 5.85%
94,454
-10,546
PRAH
7
DELISTED
PRA Health Sciences, Inc.
PRAH
$7.99M 5.45%
106,555
-33,445
EW icon
8
Edwards Lifesciences
EW
$48.4B
$7.95M 5.42%
201,798
-68,202
ABMD
9
DELISTED
Abiomed Inc
ABMD
$7.94M 5.41%
55,387
-19,613
NVRO
10
DELISTED
NEVRO CORP.
NVRO
$7.82M 5.33%
105,000
+5,000
QGEN icon
11
Qiagen
QGEN
$9.45B
$7.31M 4.98%
+205,543
SNN icon
12
Smith & Nephew
SNN
$14.1B
$6.97M 4.75%
+200,000
PTLA
13
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$6.74M 4.59%
+120,000
NBIX icon
14
Neurocrine Biosciences
NBIX
$15.2B
$6.68M 4.55%
+145,303
BKD icon
15
Brookdale Senior Living
BKD
$2.24B
$6.62M 4.51%
+450,000
ICLR icon
16
Icon
ICLR
$12.2B
$6.19M 4.22%
+63,342
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$104B
$5.95M 4.06%
46,202
-33,959
ALGN icon
18
Align Technology
ALGN
$9.67B
$5.09M 3.47%
+33,904
ILMN icon
19
Illumina
ILMN
$18.6B
$4.77M 3.25%
+28,270
ISRG icon
20
Intuitive Surgical
ISRG
$199B
$4.68M 3.19%
+45,000
BMY icon
21
Bristol-Myers Squibb
BMY
$95B
– –
-200,000
BIIB icon
22
Biogen
BIIB
$22.8B
– –
-46,320
GMED icon
23
Globus Medical
GMED
$11.3B
– –
-400,000
MDRX
24
DELISTED
Veradigm Inc. Common Stock
MDRX
– –
-590,000
NUVA
25
DELISTED
NuVasive, Inc.
NUVA
– –
-123,317
1
2